New study confirms ColdZyme stops viruses causing Covid-19 from adhering to human respiratory cells
A study published in the journal Respiratory Research confirms the previous findings from a research group at the Medical University of Innsbruck, Austria: The prescription free mouth spray ColdZyme blocks the widespread and highly transmissible omicron variants BA.4 and BA.5 from adhering to and infecting human cells. According to the researchers, this opens for the possibility that ColdZyme can be applied in the prevention of SARS-CoV-2 spreading.The world has started to breathe more easily as vaccine innovation protects millions worldwide from the many infectious viruses that cause Covid-